Ignite Creation Date:
2024-05-06 @ 5:11 PM
Last Modification Date:
2024-10-26 @ 2:23 PM
Study NCT ID:
NCT05222165
Status:
WITHDRAWN
Last Update Posted:
2023-02-23
First Post:
2022-01-12
Brief Title:
Study With Infigratinib in Subjects With Advanced Solid and CNS Tumors or Recurrent or Progressive Low-Grade Glioma With Selected FGFR1-3 Alterations
Sponsor:
Organization:
Helsinn Healthcare SA